lawsuit semaglutide Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" dallas semaglutide gastroparesis law office

[Article] [PubMed] [PMC]93

Not peptides, but commonly offered alongside them Under FDA review BPC-157, TB-500, KPV, MOTS-C on the July 2026 agenda DSIP, Semax, Epitalon on the July 2026 agenda GHK-Cu second review by Feb 2027 CJC-1295 and Ipamorelin were declined in 2024 and remain restricted, not coming back via this process

Why choose packets: Portion-controlled

Research published in the Annals of Pharmacotherapy confirms that none of the 25 topically applied products examined listed semaglutide, tirzepatide, or another FDA-approved GLP-1 agonist as an active ingredient

Some are prescribed for type 2 diabetes, some are prescribed for weight loss, and some are compared for both their metabolic and cardiovascular effects